Blastic plasmacytoid dendritic cell neoplasms – a report of two cases

1Department of Hematology, Medical University of Łódź Head of Department: prof. Tadeusz Robak, MD, PhD 2Department of Experimental Hematology, Medical University of Łódź Head of Department: prof. Piotr Smolewski, MD, PhD 3Department of Pathology, Medical University of Łódź Head of Department: prof. Radzisław Kordek, MD, PhD 4Department of Cytogenetic, The Maria Skłodowska-Curie Memorial Cancer Center and Institute, Warsaw Head of Department: Barbara Pieńkowska-Grela, MD, PhD

[1]  M. Salama,et al.  An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder. , 2011, The American Journal of dermatopathology.

[2]  Xiao-hong Chen,et al.  Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature. , 2011, Pathology, research and practice.

[3]  L. Cerroni,et al.  Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients , 2010, The American journal of surgical pathology.

[4]  R. Marchione,et al.  CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor). , 2008, Dermatology online journal.

[5]  C. Massone,et al.  CD4‐negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases , 2008, Journal of cutaneous pathology.

[6]  E. Hsi,et al.  CD4+/CD56+ hematodermic neoplasm (blastic NK‐cell lymphoma) , 2008, Journal of cutaneous pathology.

[7]  Z. Argényi,et al.  CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T‐cell receptor gene rearrangement , 2008, Journal of cutaneous pathology.

[8]  S. Piña‐Oviedo,et al.  CD4+/CD56+ Hematodermic Neoplasm: Presentation of 2 Cases and Review of the Concept of an Uncommon Tumor Originated in Plasmacytoid Dendritic Cells Expressing CD123 (IL-3 Receptor α) , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[9]  G. Pinkus,et al.  CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. , 2007, American journal of clinical pathology.

[10]  M. Herling,et al.  CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. , 2007, American journal of clinical pathology.

[11]  M. Herling,et al.  Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms , 2006, Modern Pathology.

[12]  K. Sułek,et al.  Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). , 2006, Blood.

[13]  R. Dummer,et al.  CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. , 2005, Human pathology.

[14]  C. Aul,et al.  Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes , 2004, Annals of Hematology.

[15]  T. Petrella,et al.  `Agranular CD4+ CD56+ Hematodermic Neoplasm' (Blastic NK-Cell Lymphoma) Originates From a Population of CD56+ Precursor Cells Related to Plasmacytoid Monocytes , 2002, The American journal of surgical pathology.

[16]  K. Ooya,et al.  A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature. , 1998, American journal of clinical pathology.

[17]  J. Bennett,et al.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. , 2012, Leukemia research.

[18]  L. Shaffer,et al.  ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .

[19]  M. Béné,et al.  CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. , 2003, Haematologica.